ARCHIVES

FDA Describes Meeting With NCI In “Limited” Memo

This article is from The Cancer Letter archive.

Vol. 02 No. 19 | May 7, 1976

Download PDF Visit The Full Archive

Related Articles

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

AACR, Kellogg’s Co. Sponsor Award

January 5, 1996

NIH Issues Interim Guidelines For Research Using fetal Tissue

March 26, 1993

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

September 17, 2010